Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GCLM ELISA Kit (AC3807)
Cat.#: ASET-2396
Specifications
Description Human GCLM ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human GCLM concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 14.65 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 300-4800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1807 Human Synaptotagmin VII ELISA Kit (AC3218) Quantitative inquiry ASET-1230 Mouse DLK-1 ELISA Kit (AC2641) Quantitative inquiry ASET-1407 Human BMAL1 ELISA Kit (AC2818) Quantitative inquiry ASET-1728 Porcine iNOS ELISA Kit (AC3139) Quantitative inquiry ASET-2531 Rat Tyrosine Hydroxylase ELISA Kit (AC3942) Quantitative inquiry ASET-1303 Mouse Neurotrophin 3 ELISA Kit (AC2714) Quantitative inquiry ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-1750 Human alpha Synuclein ELISA Kit (AC3161) Quantitative inquiry ASET-1556 Rat CYP1B1 ELISA Kit (AC2967) Quantitative inquiry ASET-1048 Human Profilin 1 ELISA Kit (AC2459) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket